HealthCare Global Enterprises Limited reported a significant improvement in profitability for the quarter ended June 30, 2026, with consolidated net profit (after tax and exceptional items) rising to ₹1,646 lakhs from ₹598 lakhs in the corresponding quarter ended June 30, 2025. The results were reviewed by the audit committee and approved by the board of directors at their meeting held on August 06, 2026.

Consolidated Financial Performance

On a consolidated basis, total income for the quarter ended June 30, 2026 grew to ₹70,723 lakhs, compared to ₹61,999 lakhs in the corresponding quarter ended June 30, 2025, and ₹66,540 lakhs in the preceding quarter ended March 31, 2026. Net profit before tax and exceptional items stood at ₹2,503 lakhs for the quarter, compared to ₹1,192 lakhs in the year-ago quarter and ₹3,316 lakhs in the preceding quarter. No exceptional items were recorded in the quarter ended June 30, 2026, unlike the preceding quarter ended March 31, 2026, which had a net exceptional loss of ₹3,191 lakhs.

The net profit attributable to equity shareholders of the company on a consolidated basis was ₹1,377 lakhs for the quarter ended June 30, 2026, compared to ₹475 lakhs in the corresponding quarter ended June 30, 2025 and ₹217 lakhs in the preceding quarter ended March 31, 2026. Total comprehensive income attributable to equity shareholders stood at ₹1,424 lakhs for the quarter.

The following table summarises the consolidated financial results:

Standalone Financial Performance

On a standalone basis, HealthCare Global Enterprises reported total income of ₹38,622 lakhs for the quarter ended June 30, 2026, up from ₹33,503 lakhs in the corresponding quarter ended June 30, 2025 and ₹36,513 lakhs in the preceding quarter ended March 31, 2026. Net profit before tax and exceptional items was ₹748 lakhs, compared to ₹524 lakhs in the year-ago quarter. Net profit after tax and exceptional items stood at ₹558 lakhs, against ₹345 lakhs in the corresponding quarter ended June 30, 2025 and ₹153 lakhs in the preceding quarter ended March 31, 2026.

The following table summarises the standalone financial results:

Earnings Per Share

On a consolidated basis, basic and diluted earnings per share (of ₹10 each) for the quarter ended June 30, 2026 stood at ₹0.92 each, compared to ₹0.34 (basic) and ₹0.33 (diluted) in the corresponding quarter ended June 30, 2025. On a standalone basis, basic and diluted EPS for the quarter were ₹0.37 each, against ₹0.25 (basic) and ₹0.24 (diluted) in the year-ago quarter. The equity share capital remained unchanged at ₹14,930 lakhs for the quarter ended June 30, 2026, compared to ₹13,942 lakhs in the corresponding quarter ended June 30, 2025.

Notes and Disclosures

The financial results represent an extract from the detailed format of quarterly financial results filed with the stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The figures for the preceding quarter ended March 31, 2026 are balancing figures between audited figures for the full previous financial year and the published unaudited year-to-date figures up to the end of the third quarter of the previous financial year, which were subject to limited review by the statutory auditors. The full format of the quarterly financial results is available on the websites of NSE Limited, BSE Limited, and the company's website.

Healthcare Global Enterprises Limited has released the transcript of its earnings call, providing investors access to management’s commentary on the company’s financial performance for the first quarter of FY27. The audio recording of the discussion with analysts and investors is now available on the company’s investor relations website, following the earlier intimation dated July 27, 2026.

The earnings call was conducted on August 07, 2026, to review the unaudited financial results for the quarter ended June 30, 2026. The discussion covered both standalone and consolidated figures, offering insights into the operational and financial health of the healthcare services provider during the period.

Regulatory Compliance

The disclosure was made in accordance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was submitted to the Compliance Departments of both the National Stock Exchange of India Limited and BSE Limited, ensuring timely dissemination of material information to the market.

Accessing the Earnings Call

Investors and analysts can access the full audio recording of the earnings call via the company’s official website. The link directs users to the investor relations section, where the recording is hosted for public viewing. This transparency measure allows stakeholders to hear directly from management regarding the quarterly performance and strategic outlook.

What the Numbers Show

While the specific financial metrics such as net profit, revenue, or EBITDA are not detailed in this particular filing, the release of the earnings call transcript signifies the completion of the quarterly reporting cycle for Q1FY27. The availability of the recording enables detailed analysis of management’s narrative surrounding the financial results, which may include commentary on patient volumes, margin trends, and capital expenditure plans that are not captured in the raw numbers alone.